(201) 733-5255
Contact

Biologic Injections During Hip Labral Repair

The hip labrum is a ring of cartilage that surrounds the socket of the hip joint providing stability and cushioning for the joint. The labrum plays a crucial role hip joint function and health.

The hip labrum can be damaged or torn due to various reasons. Common causes include trauma, repetitive motions in sports, and degenerative changes. Femoroacetabular impingement (FAI) is a structural hip abnormality and a common cause of hip labral tears.

Labral tears can lead to pain, stiffness, and reduced range of motion in the hip. Surgery to treat a labral tear is typically performed arthroscopically.

Hip labral repair is a surgical procedure used to correct a tear in the labrum of the hip joint. Hip labral repair is the gold standard choice to preserve the hip joint.

Biologics or biologic therapies are a class of nondrug treatments that are developed from naturally-derived substances such as sugars, proteins, nucleic acids, and a combination of these substances, or they may be living things such as cells and tissues. They may be used to:

  • help accelerate healing of injuries and damage to bone, cartilage, muscles, ligaments and tendons
  • improve healing after surgery

There are blood derived therapies such as such as platelet-rich plasma, and cell-based therapies such as stem cells, and bone marrow concentrate. They may be isolated from blood, and other substances like hyaluronic acid, a naturally-occurring sugar molecule found in the skin and synovial fluid of joints that acts as a lubricant.

  • Blood-derived therapies such as platelet-rich plasma, deliver cytokines (proteins) that are crucial in controlling the growth and activity of immune and blood cells and control inflammation and healing substances like platelets. Other blood derived therapies include growth factors that stimulate cell mechanisms like collagen production. They are delivered to the site of injury.
  • Cellular therapies, such as bone marrow aspirate concentrate (BMAC), have the ability to produce new tissues. They include live cells injected into local tissues and include mesenchymal stem cells. Unlike blood derivatives, cell-based therapies produce a regenerative effect by incorporating them into injured tissues.

  1. Tissue Repair and Regeneration: Biologics such as platelet-rich plasma (PRP) and stem cells are used to promote the healing of damaged tissues.
  2. Surgical Healing: Biologics may be used during surgery to aid in healing from surgeries such as ACL reconstruction or rotator cuff repair. Biologics may be used to accelerate the healing process and improve the quality of the repaired tissue.

Studies have examined the use of biologics during arthroscopic surgery.  They have found that the application of platelet-rich plasma during surgery resulted in reduced pain postoperatively and reduced inflammation following hip arthroscopy.

In addition to PRP, Bone Marrow Aspirate Concentrate (BMAC) has been used intra-operatively for hip arthroscopy procedures.

  • A 2020 study found that BMAC injections at the conclusion of the arthroscopy procedure improved outcomes of both pain and function at 1- and 2-year follow-up. Moreover, BMAC are ideal because they have the ability to differentiate into cartilage. BMAC is a safe and effective option for augmentation of labral healing.
  • A 2023 study reports that intraoperative platelet-rich plasma and cell-based therapies found that cell-based therapy demonstrated more favorable patient-reported outcomes defining success in hip labral repair.

Biologics like stem cells and growth factors can be used in procedures aimed at repairing or regenerating damaged cartilage including hip labral cartilage, especially in young patients or athletes with cartilage injuries.

Biologics that are harvested from your own body and used to treat you are safe. They are not used in people with malignancies or recent remissions.

Schedule a hip consultation

You can rely on experience and qualifications of clinicians at LALL Orthopedics +. Our team aims to provide safe and effective biologics treatments to improve your healing. When you or a loved one is suffering with an orthopedic problem, you have options. Contact the team at LALL Orthopedics + to schedule a consultation to receive the correct diagnosis and modern cutting-edge treatment options. We have offices in New Jersey, Manhattan, Philadelphia, and West Palm Beach, FL.


References

  • Lall AC, Walsh JP, Maldonado DR, Pinto LE, Ashberg LJ, Lodhia P, Radha S, Correia APR, Domb BG, Perez-Carro L, Marín-Peña O, Griffin DR. Teamwork in hip preservation: the ISHA 2019 Annual Scientific Meeting. J Hip Preserv Surg. 2020 Oct 9;7(Suppl 1):2-21. doi: 10.1093/jhps/hnaa037. PMID: 33072394; PMCID: PMC7546541.
  • Rafols C, Monckeberg JE, Numair J, Botello J, Rosales J. Platelet-Rich Plasma Augmentation of Arthroscopic Hip Surgery for Femoroacetabular Impingement: A Prospective Study With 24-Month Follow-up. Arthroscopy. 2015 Oct;31(10):1886-92. doi: 10.1016/j.arthro.2015.03.025. Epub 2015 May 15. PMID: 25980923.
  • Stelzer JW, Martin SD. Use of Bone Marrow Aspirate Concentrate with Acetabular Labral Repair for the Management of Chondrolabral Junction Breakdown. Arthrosc Tech. 2018 Sep 1;7(10):e981-e987. doi: 10.1016/j.eats.2018.06.003. PMID: 30377577; PMCID: PMC6203226.
  • Rivera E, Seijas R, Rubio M. et al. Outcomes at 2-years follow-up after hip arthroscopy combining bone marrow concentrate. J Investig Surg 2020; 33: 655–63.
  • George T, Curley AJ, Saeed SK, Kuhns BD, Parsa A, Domb BG. Orthobiologics as an adjunct in treatment of femoroacetabular impingement syndrome: cell-based therapies facilitate improved postoperative outcomes in the setting of acetabular chondral lesions-a systematic review. Knee Surg Sports Traumatol Arthrosc. 2023 Dec;31(12):6020-6038. doi: 10.1007/s00167-023-07624-4. Epub 2023 Oct 31. PMID: 37906291.
  • Lall AC, Walsh JP, Maldonado DR, Pinto LE, Ashberg LJ, Lodhia P, Radha S, Correia APR, Domb BG, Perez-Carro L, Marín-Peña O, Griffin DR. Teamwork in hip preservation: the ISHA 2019 Annual Scientific Meeting. J Hip Preserv Surg. 2020 Oct 9;7(Suppl 1):2-21. doi: 10.1093/jhps/hnaa037. PMID: 33072394; PMCID: PMC7546541.
At a Glance

Ajay C. Lall, MD, MS, FAAOS

  • Board Certified – Orthopedic Surgery
  • Triple Fellowship Trained
  • Performs over 750 Surgeries Per Year
  • Learn more